Wealth Enhancement Advisory Services, LLC Corcept Therapeutics Inc Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 13,647 shares of CORT stock, worth $961,431. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,647
Previous 7,954
71.57%
Holding current value
$961,431
Previous $908,000
10.24%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CORT
# of Institutions
470Shares Held
84.5MCall Options Held
1.42MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.17 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$703 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$544 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$433 Million1.13% of portfolio
-
Parallel Advisors, LLC3.87MShares$273 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.55B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...